Wearable Robotics

Wearable Robotics is a Pisa-based spin-off that develops exoskeletons and wearable robotic devices for neuromotor rehabilitation, targeting patients recovering from stroke, spinal cord injury, and neurodegenerative conditions. The distinction from industrial exoskeletons — the wearable systems designed to augment the physical strength of healthy workers in manufacturing, logistics, or construction — is fundamental and clinically significant: Wearable Robotics' devices are CE-certified medical instruments engineered to guide, support, and progressively challenge the movement of patients with motor impairments in both clinical rehabilitation settings and, increasingly, in supervised home environments. The technology centers on soft actuator systems and adaptive control algorithms that continuously sense each patient's movement intention in real time — through electromyography sensors that detect the electrical activity of muscles attempting to contract, or through force sensors that register the mechanical effort the patient is generating — and respond by providing precisely calibrated mechanical assistance in the direction and at the intensity level that the movement attempt requires. This clinical approach, formally known in rehabilitation medicine as assist-as-needed, is considered the evidence-based gold standard in robotic rehabilitation. The rationale is neurophysiological: motor recovery after neurological injury is maximized when the brain is actively and effortfully engaged in initiating and completing movement, not when movement is passively performed for the patient by an external system. A robot that assists the patient's own motor effort rather than replacing it promotes neuroplasticity — the brain's capacity to reorganize and strengthen neural pathways — in a way that fully automated movement does not and cannot. The clinical evidence base for robotic rehabilitation is substantial and continuing to grow. For stroke survivors in particular, the correlation between the intensity and repetition of motor practice and the degree of functional recovery is well established. Robotic systems can deliver hundreds of precisely controlled, biomechanically consistent repetitions per therapy session at intensities that human therapists cannot maintain across a full clinical day, and they generate objective kinematic and force data that enables clinicians to monitor recovery trajectories and adapt treatment protocols with a precision that observation-based assessment cannot match. With a €5 million Series A completed, Wearable Robotics is expanding its commercial footprint toward rehabilitation hospitals, specialist neurological rehabilitation centers, and long-term care facilities in Italy and across Europe. The market for robotic rehabilitation is growing steadily, driven by demographic aging, rising stroke and neurological disease incidence, and growing recognition among healthcare administrators, clinical researchers, and health economics analysts that technology-assisted intensive rehabilitation generates better long-term outcomes at competitive cost compared to conventional physiotherapy alone — particularly when the comparison accounts for the full trajectory of patient recovery and reduced long-term care dependency.